T-Cell Response to Vaccination

T-Cell Response to Vaccination
Recruiting
18 years - 65 years
All
Phase N/A
1 Location

Brief description of study

The purpose of this study is to see how your body responds to a vaccine and how your body forms a protective response after vaccination. In this study we will use the yellow fever vaccine, an FDA approved vaccine that is commonly given to people traveling to certain parts of Africa and South America.

Detailed description of study

The study consists of a screening visit followed by 9 study visits. From the time of screening, you will be in this study for between 8-12 months. The study include: Screening visit (approx 1 hour), Study visit 1 - Luekopheresis (approx 2.5 hours), Study Visit 2 - Vaccination (approx 45 mins), Study Visits 3-8 - Blood Draws (approx 30 mins), Study Visit 9 - Leukopheresis (approx 2.5 hours).

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: healthy Volunteers,healthy subjects,Healthy,Healthy volunteer,healthy,healthy volunteer,healthy volunteers,healthy subjects,healthy
  • Age: 18 years - 65 years
  • Gender: All


Updated on 10 Dec 2025. Study ID: 820884

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.